Casdin Capital, LLC Care Dx, Inc. Transaction History

Casdin Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$20.49 - $39.72 $23.6 Million - $45.8 Million	-1,153,335 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$41.2 - $73.6 $1.65 Million - $2.94 Million	-40,000 Reduced 3.35%	1,153,335 $52.5 Million
Q2 2020 Aug 14, 2020	SELL	$18.95 - $35.43 $1.91 Million - $3.58 Million	-101,000 Reduced 7.8%	1,193,335 $42.3 Million
Q1 2020 May 15, 2020	BUY	$13.94 - $28.25 $1.32 Million - $2.66 Million	94,335 Added 7.86%	1,294,335 $28.3 Million
Q4 2019 Feb 14, 2020	BUY	$19.24 - $28.41 $3.85 Million - $5.68 Million	200,000 Added 20.0%	1,200,000 $25.9 Million
Q3 2019 Nov 12, 2019	BUY	$20.03 - $40.08 $16 Million - $32.1 Million	800,000 Added 400.0%	1,000,000 $22.6 Billion
Q2 2018 Aug 14, 2018	BUY	$7.93 - $15.79 $1.59 Million - $3.16 Million	200,000 New	200,000 $2.45 Million

219

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.